ARCHIVES

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Stop Cancer Changes Leaders, Focus, Sends $1.6M To NCI

August 30, 1991

Northwestern, Rochester, Howard First In Line For Limited Construction Funds

August 20, 1976

Appropriations: Senate Committee Approves 4.5 Percent Cut To Defense Dept. Cancer Research Funding

July 25, 2014

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

Medical Advances Not Driven Entirely By Science, Author Physician Barron Lerner Tells Journalists

March 22, 2002

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991